Status:

COMPLETED

A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)

Lead Sponsor:

GlaxoSmithKline

Conditions:

Asthma

Eligibility:

All Genders

Brief Summary

The CATO population is a very well documented population during two years. During this study patients were treated according to the CATO algorithm, after that patient were treated according to the Dut...

Detailed Description

A long term follow up study for a comparison of stepwise treatment of asthmatic children with Salmeterol/Fluticasone propionate combination product (Seretide®) and/or Fluticasone propionate (Flixotide...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Any subject who has given informed consent to participate in the CATO study, and has met all the criteria required for randomisation into the clinical study may take part in this follow up study
  • Under the age of 18 years Subjects and both parent(s)/guardian(s) who have given written informed consent to participate in the study
  • Subjects from 18 years and older who have given written informed consent to participate in the study
  • Exclusion criteria:
  • Experienced an acute asthma exacerbation requiring emergency room treatment within 4 weeks or hospitalisation within 4 weeks of visit 1
  • Any use of oral/parenteral or depot corticosteroid within 4 weeks of visit 1
  • Subjects who are pregnant (a pregnancy test can be performed at the investigator's discretion)

Exclusion

    Key Trial Info

    Start Date :

    January 1 2007

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    October 1 2007

    Estimated Enrollment :

    137 Patients enrolled

    Trial Details

    Trial ID

    NCT00441675

    Start Date

    January 1 2007

    End Date

    October 1 2007

    Last Update

    March 19 2012

    Active Locations (15)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 4 (15 locations)

    1

    GSK Investigational Site

    Alkmaar, Netherlands, 1815 JD

    2

    GSK Investigational Site

    Almere Stad, Netherlands, 1315 RA

    3

    GSK Investigational Site

    Amsterdam, Netherlands, 1081 HV

    4

    GSK Investigational Site

    Amsterdam, Netherlands, 1105 AZ